Immune complexes stimulate CCR7-dependent dendritic cell migration to lymph nodes

Nature Medicine

Volumn 20, Issue 12, 2014, Pages 1458-1463

  Clatworthy, Menna R ^a,b   Aronin, Caren E Petrie ^b   Mathews, Rebeccah J ^a   Morgan, Nicole Y ^c   Smith, Kenneth G C ^d   Germain, Ronald N ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; CHEMOKINE RECEPTOR CCR7; FC RECEPTOR; FC RECEPTOR IIB; MACROPHAGE INFLAMMATORY PROTEIN 3BETA;

ANIMAL; ANTIGEN ANTIBODY COMPLEX; CELL MOTION; DENDRITIC CELL; HUMAN; IMMUNOLOGY; LANGERHANS CELL; LYMPH NODE; MOUSE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CELL MOVEMENT; CHEMOKINE CCL19; DENDRITIC CELLS; HUMANS; LANGERHANS CELLS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPH NODES; MICE; RECEPTORS, CCR7; RECEPTORS, IGG;

EID: 84939957818     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3709     Document Type: Article

References (45)

1. Banchereau, J. & Steinman, R.M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998).
2. Steinman, R.M. Decisions about dendritic cells: past, present, and future. Annu. Rev. Immunol. 30, 1-22 (2012).
3. Krause, R.M., Dimmock, N.J. & Morens, D.M. Summary of antibody workshop: the role of humoral immunity in the treatment and prevention of emerging and extant infectious diseases. J. Infect. Dis. 176, 549-559 (1997).
4. Joller, N., Weber, S.S. & Oxenius, A. Antibody-Fc receptor interactions in protection against intracellular pathogens. Eur. J. Immunol. 41, 889-897 (2011).
5. Ravetch, J.V. & Bolland, S. IgG Fc receptors. Annu. Rev. Immunol. 19, 275-290 (2001).
6. Itano, A.A. et al. Distinct dendritic cell populations sequentially present antigen to CD4 T cells and stimulate different aspects of cell-mediated immunity. Immunity 19, 47-57 (2003).
7. Hawiger, D. et al. Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194, 769-779 (2001).
8. Steinman, R.M., Hawiger, D. & Nussenzweig, M.C. Tolerogenic dendritic cells. Annu. Rev. Immunol. 21, 685-711 (2003).
9. Roake, J.A. et al. Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1. J. Exp. Med. 181, 2237-2247 (1995).
10. Reise Sousa, C. Dendritic cells in a mature age. Nat. Rev. Immunol. 6, 476-483 (2006).
11. Boruchov, A.M. et al. Activating and inhibitory IgG Fc receptors on human dendritic cells mediate opposing functions. J. Clin. Invest. 115, 2914-2923 (2005).
12. Dhodapkar, K.M. et al. Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells. Proc. Natl. Acad. Sci. USA 102, 2910-2915 (2005).
13. Dhodapkar, K.M. et al. Selective blockade of the inhibitory Fcγ receptor (FcγRIIB) in human dendritic cells and monocytes induces a type I interferon response program. J. Exp. Med. 204, 1359-1369 (2007).
14. Kalergis, A.M. & Ravetch, J.V. Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J. Exp. Med. 195, 1653-1659 (2002).
15. van Montfoort, N. et al. Fcγ receptor IIb strongly regulates fcγ receptor-facilitated T cell activation by dendritic cells. J. Immunol. 189, 92-101 (2012).
16. Pricop, L. et al. Differential modulation of stimulatory and inhibitory Fcγ receptors on human monocytes by Th1 and Th2 cytokines. J. Immunol. 166, 531-537 (2001).
17. Smith, K.G.C. & Clatworthy, M.R. FcγRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat. Rev. Immunol. 10, 328-343 (2010).
18. Bolland, S. & Ravetch, J.V. Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity 13, 277-285 (2000).
19. Brownlie, R.J. et al. Distinct cell-specific control of autoimmunity and infection by FcγRIIB. J. Exp. Med. 205, 883-895 (2008).
20. Boross, P. et al. The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibility. J. Immunol. 187, 1304-1313 (2011).
21. Floto, R.A. et al. Loss of function of a lupus-associated FcγRIIB polymorphism through exclusion from lipid rafts. Nat. Med. 11, 1056-1058 (2005).
22. Kono, H. et al. FcγRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum. Mol. Genet. 14, 2881-2892 (2005).
23. Randolph, G.J., Angeli, V. & Swartz, M.A. Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat. Rev. Immunol. 5, 617-628 (2005).
24. Cyster, J.G. Chemokines and the homing of dendritic cells to the T cell areas of lymphoid organs. J. Exp. Med. 189, 447-450 (1999).
25. Förster, R. et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99, 23-33 (1999).
26. Sallusto, F. et al. Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur. J. Immunol. 28, 2760-2769 (1998).
27. Ratzinger, G. et al. Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168, 4361-4371 (2002).
28. Yen, J.H., Khayrullina, T. & Ganea, D. PGE2-induced metalloproteinase-9 is essential for dendritic cell migration. Blood 111, 260-270 (2008).
29. Lebre, M.C., Kalinski, P., Das, P.K. & Everts, V. Inhibition of contact sensitizer-induced migration of human Langerhans cells by matrix metalloproteinase inhibitors. Arch. Dermatol. Res. 291, 447-452 (1999).
30. Kobayashi, Y., Matsumoto, M., Kotani, M. & Makino, T. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 163, 5989-5993 (1999).
31. Ichiyasu, H. et al. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am. J. Respir. Cell Mol. Biol. 30, 761-770 (2004).
32. Rahman, A. & Isenberg, D.A. Systemic lupus erythematosus. N. Engl. J. Med. 358, 929-939 (2008).
33. Blanco, P., Palucka, A.K., Gill, M., Pascual, V. & Banchereau, J. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294, 1540-1543 (2001).
34. Decker, P., Kotter, I., Klein, R., Berner, B. & Rammensee, H.G. Monocyte-derived dendritic cells over-express CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 45, 1087-1095 (2006).
35. Ding, D., Mehta, H., McCune, W.J. & Kaplan, M.J. Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus. J. Immunol. 177, 5878-5889 (2006).
36. Crispín, J.C., Vargas-Rojas, M.I., Monsivais-Urenda, A. & Alcocer-Varela, J. Phenotype and function of dendritic cells of patients with systemic lupus erythematosus. Clin. Immunol. 143, 45-50 (2012).
37. Willcocks, L.C. et al. A defunctioning polymorphism in FCGR2B is associated with protection against malaria but susceptibility to systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 107, 7881-7885 (2010).
38. + T-cell/dendritic cell interactions in vivo. Cell. Immunol. 214, 110-122 (2001).
39. Lindquist, R.L. et al. Visualizing dendritic cell networks in vivo. Nat. Immunol. 5, 1243-1250 (2004).
40. Lämmermann, T. et al. Rapid leukocyte migration by integrin-independent flowing and squeezing. Nature 453, 51-55 (2008).
41. Bowden, E.T., Coopman, P.J. & Mueller, S.C. Invadopodia: unique methods for measurement of extracellular matrix degradation in vitro. Methods Cell Biol. 63, 613-627 (2001).
42. Haessler, U., Pisano, M., Wu, M. & Swartz, M.A. Dendritic cell chemotaxis in 3D under defined chemokine gradients reveals differential response to ligands CCL21 and CCL19. Proc. Natl. Acad. Sci. USA 108, 5614-5619 (2011).
43. Tal, O. et al. DC mobilization from the skin requires docking to immobilized CCL21 on lymphatic endothelium and intralymphatic crawling. J. Exp. Med. 208, 2141-2153 (2011).
44. Zinselmeyer, B.H., Lynch, J.N., Zhang, X., Aoshi, T. & Miller, M.J. Video-rate two-photon imaging of mouse footpad-a promising model for studying leukocyte recruitment dynamics during inflammation. Inflamm. Res. 57, 93-96 (2008).
45. Robbiani, D.F. et al. The leukotriene C(4) transporter MRP1 regulates CCL19 (MIP-3β, ELC)-dependent mobilization of dendritic cells to lymph nodes. Cell 103, 757-768 (2000).